Fundraising Fox

Vytalyx

Austin, US · Founded 2017 · Delaware corporation

Biotech

Founders & leadership

DV
David ValentiNamed on SEC filing
GP
Gary PikeNamed on SEC filing
JH
Jeffrey HellerNamed on SEC filing
JH
John HartwigNamed on SEC filing
AS
Andre Silvio GranzottiNamed on SEC filing
DW
Dave WentzNamed on SEC filing
DA
David Alexander GranzottiNamed on SEC filing
JT
Jennifer TanguyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$930K disclosed across 2 of 4 rounds · 2017–2018

▶$630KraisedNov 2018 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David P ValentiExecutive Officer
  • Jeffrey HellerExecutive Officer
  • John HartwigExecutive Officer
  • Andre Silvio GranzottiExecutive Officer, Promoter
  • David Alexander GranzottiExecutive Officer, Director, Promoter
  • Jennifer TanguyExecutive Officer, Promoter
Offering amount
$1M
Amount sold
$630K
Minimum investment
$25K
First sale
Dec 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedNov 2018 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jennifer TanguyExecutive Officer, Promoter
  • David ValentiExecutive Officer
  • Jeffrey HellerExecutive Officer
  • Dave WentzDirector
  • John HartwigExecutive Officer, Director
  • David Alexander GranzottiExecutive Officer, Director, Promoter
  • Andre Silvio GranzottiExecutive Officer, Promoter
  • Gary PikeExecutive Officer
Offering amount
$300K
Amount sold
$300K
Minimum investment
$25K
First sale
May 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MofferedMay 2018 · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • David ValentiExecutive Officer
  • Gary PikeExecutive Officer
  • Jeffrey HellerExecutive Officer
  • John HartwigExecutive Officer
  • Andre Silvio GranzottiExecutive Officer, Director, Promoter
  • Dave WentzDirector
  • David Alexander GranzottiExecutive Officer, Director, Promoter
  • Jennifer TanguyExecutive Officer, Promoter
Offering amount
$60M
Minimum investment
$50K
Sales commissions
$3M
Proceeds to insiders
$1.7M
Placement agents
Boustead Securities LLC
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$27.5MofferedMay 2018 · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • David ValentiExecutive Officer
  • David Alexander GranzottiExecutive Officer, Director, Promoter
  • Gary PikeExecutive Officer
  • Jennifer TanguyExecutive Officer, Promoter
  • Dave WentzDirector
  • Andre Silvio GranzottiExecutive Officer, Director, Promoter
  • Jeffrey HellerExecutive Officer
  • John HartwigExecutive Officer
Offering amount
$27.5M
Minimum investment
$275K
Sales commissions
$1.4M
Proceeds to insiders
$1.7M
Placement agents
Boustead Securities LLC
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Vytalyx Appoints Asad Mahmood, M.D. as Strategic Advisorprnewswire.com · Jun 2018

Frequently asked questions

How much funding has Vytalyx raised?
Vytalyx has disclosed $930K raised across 2 of its 4 known rounds.
Where is Vytalyx headquartered?
Vytalyx is headquartered in Austin, US.